Top News

Cidara Therapeutics Gets $32M

San Diego-based Cidara Therapeutics, a new, startup biopharmaceuticals firm working on treatments for severe fungal infections, has raised $32M in a Series A funding. The funding was led by 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners, as well as un-named institutional investors. According to the company, it is working on a long acting echinocandin antifungal drug which is being targeted at use in fighting severe fungal infections in immune compromised patients. The company said it has appointed Jeffrey Stein--former CEO of Trius Therapeutics--as its new President and CEO. The company was co-founded by Kevin Forrest (5AM Ventures), Kevin Judice (Acahogen Pharmaceuticals) and H. Shaw Warren (Harvard University, Massachusetts General Hospital).


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel